Shannon Devers sold $59K of Ionis Pharmaceuticals stock
By AlphaYouPublished Form 4
Devers Shannon L.
Reporting filer
Shannon Devers reported selling 1,357 shares of Ionis Pharmaceuticals Inc for about $59K ($43.54 a share on average). Form 4 filed Oct 20, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 20, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Devers Shannon L. | 2026-10-15 | M | Exercise or conversion | 2820 | 0.0 | 19,168 | 5 days | Filed terms
|
| Common Stock | Devers Shannon L. | 2026-10-16 | S | Sale | 1357 | 43.5386 | 17,811 | 4 days | Filed terms
|
| Restricted Stock Unit (derivative) | Devers Shannon L. | 2026-10-15 | M | Exercise or conversion | 2820 | 0.0 | 49,884 | 5 days | Filed terms
|
Common Stock
- Owner
- Devers Shannon L.
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 2820
- Price
- 0.0
- Following holdings
- 19,168
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2820
- id: F1
- transaction Price Per Share: 0.0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 19168
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Devers Shannon L.
- Date
- 2026-10-16
- Code
- S
- Action
- Sale
- Quantity
- 1357
- Price
- 43.5386
- Following holdings
- 17,811
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 1357
- id: F2
- transaction Price Per Share: 43.5386
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 17811
- direct Or Indirect Ownership: D
Restricted Stock Unit (derivative)
- Owner
- Devers Shannon L.
- Date
- 2026-10-15
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 2820
- Price
- 0.0
- Following holdings
- 49,884
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Unit
- conversion Or Exercise Price: 0.0
- id: F4
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 2820
- transaction Price Per Share: 0.0
- transaction Acquired Disposed Code: D
- id: F5
- id: F5
- underlying Security Title: Common Stock
- underlying Security Shares: 2820
- shares Owned Following Transaction: 49884
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Devers Shannon L.: EVP, Chief Human Resources Ofc.
- F1: Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- F2: The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.1383 to $43.538918 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
- F4: Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- F5: Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Original sources
Prepared automatically from public filing data. Report a correction.